{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:04:45Z","timestamp":1775693085822,"version":"3.50.1"},"reference-count":29,"publisher":"VM Media SP. zo.o VM Group SK","issue":"4","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","oncology-and-radiotherapy.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reports of Practical Oncology &amp; Radiotherapy"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.rpor.2018.06.009","type":"journal-article","created":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T09:42:05Z","timestamp":1532598125000},"page":"290-297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Permanent seed implant brachytherapy in low-risk prostate cancer: Preoperative planning with 145\u202fGy versus real-time intraoperative planning with 160\u202fGy"],"prefix":"10.5603","volume":"23","author":[{"given":"Olga","family":"Pons-Llanas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana","family":"Roldan-Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Celada-Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Perez-Calatayud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Fornes-Ferrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Tormo-Mic\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Perez-Calatayud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"L\u00f3pez-Torrecilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3595","reference":[{"key":"10.1016\/j.rpor.2018.06.009_bib0005","series-title":"Cancer incidence in five continents, vol. X. IARC Scientific Publication N. 164","year":"2017"},{"key":"10.1016\/j.rpor.2018.06.009_bib0010","unstructured":"Registro Nacional de Prostate cancer-Asociaci\u00f3n Espa\u00f1ola de Urolog\u00eda, www.aeu.es\/userfiles\/presentacion_datos_nacionales_registro_nacional_cap.pdf."},{"key":"10.1016\/j.rpor.2018.06.009_bib0015","series-title":"National Comprehensive Cancer Network Guidelines","year":"2016"},{"key":"10.1016\/j.rpor.2018.06.009_bib0020","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0360-3016(99)00526-X","article-title":"Comparison of biochemical disease-free survival of patients with localized carcinoma of the prostate undergoing radical prostatectomy, transperineal ultrasound-guided radioactive seed implantation, or definitive external beam irradiation","volume":"47","author":"Steven","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.rpor.2018.06.009_bib0025","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.brachy.2011.07.005","article-title":"American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy","volume":"11","author":"Davis","year":"2012","journal-title":"Brachytherapy"},{"issue":"3","key":"10.1016\/j.rpor.2018.06.009_bib0030","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0167-8140(00)00306-6","article-title":"ESTRO\/EAU\/EORTC recommendations on permanent seed implantation for localized prostate cancer","volume":"57","author":"Ash","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.rpor.2018.06.009_bib0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.radonc.2007.01.014","article-title":"Tumour and target volumes in permanent prostate brachytherapy: a supplement to the ESTRO\/EAU\/EORTC recommendations on prostate brachytherapy","volume":"83","author":"Salembier","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.rpor.2018.06.009_bib0040","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO, Phoenix Consensus Conference","volume":"65","author":"Roach","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.rpor.2018.06.009_bib0045","unstructured":"RTOG\/EORTC Radiation Morbidity Scoring Schema. Available at www.rtog.org."},{"key":"10.1016\/j.rpor.2018.06.009_bib0050","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE). Available at www.evs.nci.nih.Gov."},{"key":"10.1016\/j.rpor.2018.06.009_bib0055","unstructured":"The R Project for Statistical Computing. R version 3.2.3 (Wooden Christmas-tree)."},{"key":"10.1016\/j.rpor.2018.06.009_bib0060","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ijrobp.2006.08.056","article-title":"Multi-institutional analysis of long-term outcome for stages T1\u2013T2 prostate cancer treated with permanent seed implantation","volume":"67","author":"Zelelefsky","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.rpor.2018.06.009_bib0065","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/bju.12358","article-title":"Five years outcomes following 125I seed brachytherapy for low risk prostate cancer at three United Kingdom cancer centers","volume":"113","author":"Dickinson","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.rpor.2018.06.009_bib0070","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.brachy.2014.11.015","article-title":"Permanent seed brachytherapy for clinically localized prostate cancer: long-term outcomes in a 700 patient cohort","volume":"14","author":"Mart\u00ednez","year":"2015","journal-title":"Brachytheapy"},{"key":"10.1016\/j.rpor.2018.06.009_bib0075","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1464-410X.2009.09096.x","article-title":"Prostate-specific antigen relapse-free survival and side-effects in 734 patients with up to 10 years of follow-up with localized prostate cancer treated by permanent 125Iodine implants","volume":"106","author":"Prada","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.rpor.2018.06.009_bib0080","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ijrobp.2010.05.042","article-title":"Fifteen-year biochemical relapse-free survival, cause-specific survival, and overall survival following 125Iodine prostate brachytherapy in clinically localized prostate cancer: Seattle experience","volume":"81","author":"Silvester","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.rpor.2018.06.009_bib0085","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.radonc.2013.05.038","article-title":"Quality of life impact of treatments for localized prostate cancer: Cohort study with a 5 year follow-up","volume":"108","author":"Ferrer","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.rpor.2018.06.009_bib0090","first-page":"218","article-title":"Predictive factors for urinary toxicity after iodine-125 prostate brachytherapy with or without supplemental external beam radiotherapy","volume":"15","author":"Takahisa","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.rpor.2018.06.009_bib0095","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ijrobp.2014.06.037","article-title":"Late urinary side effects 10 years after low-dose-rate brachytherapy: population-based results from a multiphysician practice treating with a standardized protocol and uniform dosimetric goals","volume":"90","author":"Keyes","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"288","key":"10.1016\/j.rpor.2018.06.009_bib0100","article-title":"Comparison between preoperative and real-time intraoperative planning 125I permanent prostate brachytherapy: long-term clinical biochemical outcome","volume":"8","author":"Matzkin","year":"2013","journal-title":"Radiat Oncol"},{"issue":"4","key":"10.1016\/j.rpor.2018.06.009_bib0105","doi-asserted-by":"crossref","first-page":"258","DOI":"10.5114\/jcb.2015.53525","article-title":"Comparison of permanent I125 seeds implants with two different techniques in 500 cases of prostate cancer","volume":"7","author":"Guinot","year":"2015","journal-title":"J Contemp Brachyther"},{"issue":"1","key":"10.1016\/j.rpor.2018.06.009_bib0110","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5114\/jcb.2015.48603","article-title":"Comparison of three different techniques of low-dose-rate seed implantation for prostate cancer","volume":"7","author":"Ishiyama","year":"2015","journal-title":"J Contemp Brachyther"},{"key":"10.1016\/j.rpor.2018.06.009_bib0115","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1088\/0031-9155\/48\/17\/302","article-title":"Dose escalation in permanent brachytherapy for prostate cancer: dosimetric and biological considerations","volume":"48","author":"Li","year":"2003","journal-title":"Phys Med Biol"},{"issue":"3","key":"10.1016\/j.rpor.2018.06.009_bib0120","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0090-4295(03)00407-2","article-title":"Iodine-125 brachytherapy for localized prostate cancer and urinary morbidity: a prospective comparison of two seed implant methods-preplanning and intraoperative planning","volume":"62","author":"Matzkin","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.rpor.2018.06.009_bib0125","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0360-3016(98)00152-7","article-title":"Edema associated with I-125 or Pd-103 prostate brachytherapy and its impact on post-implant dosimetry: an analysis based on serial CT acquisition","volume":"41","author":"Waterman","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.rpor.2018.06.009_bib0130","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ijrobp.2009.07.1723","article-title":"Biochemical disease-free rate and toxicity for men treated with Iodine-125 prostate cancer with D90\u202f>\u202f180\u202fGy","volume":"78","author":"G\u00f3mez-Iturriaga","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.rpor.2018.06.009_bib0135","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.brachy.2004.05.001","article-title":"MRI-CT fusion to assess postbrachytherapy prostate volume and the effects of prolonged edema on dosimetry following transperineal interstitial permanent prostate brachytherapy","volume":"3","author":"Crook","year":"2004","journal-title":"Brachytherapy"},{"key":"10.1016\/j.rpor.2018.06.009_bib0140","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1088\/0031-9155\/52\/11\/012","article-title":"Dosimetry accuracy as a function of seed localization uncertainty in permanent prostate brachytherapy: increased seed number correlates with less variability in prostate dosimetry","volume":"52","author":"Su","year":"2007","journal-title":"Phys Med Biol"},{"issue":"1","key":"10.1016\/j.rpor.2018.06.009_bib0145","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijrobp.2007.06.067","article-title":"125I monotherapy using D90 implant doses of 180\u202fGy or greater","volume":"70","author":"Kao","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Reports of Practical Oncology &amp; Radiotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1507136718300762?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1507136718300762?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T14:14:45Z","timestamp":1613657685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1507136718300762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S1507136718300762"],"URL":"https:\/\/doi.org\/10.1016\/j.rpor.2018.06.009","relation":{},"ISSN":["1507-1367"],"issn-type":[{"value":"1507-1367","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Permanent seed implant brachytherapy in low-risk prostate cancer: Preoperative planning with 145\u202fGy versus real-time intraoperative planning with 160\u202fGy","name":"articletitle","label":"Article Title"},{"value":"Reports of Practical Oncology & Radiotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpor.2018.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Greater Poland Cancer Centre. Published by Elsevier Sp. z o.o.","name":"copyright","label":"Copyright"}]}}